Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - ThermoGenesis Holdings, Inc. | ex99_1.htm |
| EX-99.3 - EXHIBIT 99.3 - ThermoGenesis Holdings, Inc. | ex99_3.htm |
| EX-99.2 - EXHIBIT 99.2 - ThermoGenesis Holdings, Inc. | ex99_2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 16, 2013
THERMOGENESIS CORP.
(Exact name of registrant as specified in its charter)
|
Delaware
|
333-82900
|
94-3018487
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2711 Citrus Road
Rancho Cordova, California 95742
(Address and telephone number of principal executive offices) (Zip Code)
(916) 858-5100
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| x | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events |
Attached hereto as Exhibits 99.1, 99.2 and 99.3 and incorporated by reference herein, are a conference call script, a question and answer presentation and a PowerPoint presentation of ThermoGenesis Corp., a Delaware corporation (the “Company”), in connection with the Agreement and Plan of Merger and Reorganization, dated July 15, 2013, among the Company and TotipotentRx Corporation.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| 99.1 | Script for conference call |
| 99.2 | ThermoGenesis and Totipotent Merger Agreement FAQ |
| 99.3 | Corporate Presentation: The Merger of ThermoGenesis Corp. and TotipotentRx July 2013 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
THERMOGENESIS CORP.,
|
|
|
|
|
a Delaware Corporation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Matthew T. Plavan
|
|
|
|
|
|
Matthew T. Plavan
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
3